Teva Pharmaceutical Industries logo

Teva Pharmaceutical Industries Share Price Today

(NASDAQ: TEVA)

Teva Pharmaceutical Industries share price is $13.65 & ₹1,165.44 as on 18 Apr 2025, 2.30 'hrs' IST

$13.65

0.22

(1.64%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Teva Pharmaceutical Industries share price in Dollar and Rupees. Guide to invest in Teva Pharmaceutical Industries stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Teva Pharmaceutical Industries, along with analyst recommendations, forecasts, and comprehensive financials.

Teva Pharmaceutical Industries share price movements

  • Today's Low: $13.45
    Today's High: $13.72

    Day's Volatility :2.0%

  • 52 Weeks Low: $12.47
    52 Weeks High: $22.80

    52 Weeks Volatility :45.33%

Teva Pharmaceutical Industries (TEVA) Returns

PeriodTeva Pharmaceutical Industries LtdSector (Health Care)Index (Russel 2000)
3 Months
-37.96%
-1.8%
0.0%
6 Months
-24.23%
-9.6%
0.0%
1 Year
6.42%
-0.5%
0.0%
3 Years
33.6%
-0.7%
-11.8%

Teva Pharmaceutical Industries (TEVA) Key Statistics

in dollars & INR

Previous Close
$13.43
Open
$13.54
Today's High
$13.72
Today's Low
$13.445
Market Capitalization
$15.6B
Today's Volume
$7.2M
52 Week High
$22.8
52 Week Low
$12.465
Revenue TTM
$16.5B
EBITDA
$4.4B
Earnings Per Share (EPS)
$-1.45
Profit Margin
-9.91%
Quarterly Earnings Growth YOY
0.4%
Return On Equity TTM
-28.3%

How to invest in Teva Pharmaceutical Industries Stock (TEVA) from India?

It is very easy for Indian residents to invest directly in Teva Pharmaceutical Industries from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Teva Pharmaceutical Industries stock in both Indian Rupees (INR) and US Dollars (USD). Search for Teva Pharmaceutical Industries or TEVA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Teva Pharmaceutical Industries or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Teva Pharmaceutical Industries shares which would translate to 0.063 fractional shares of Teva Pharmaceutical Industries as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Teva Pharmaceutical Industries, in just a few clicks!

Returns in Teva Pharmaceutical Industries (TEVA) for Indian investors in Rupees

The Teva Pharmaceutical Industries stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Teva Pharmaceutical Industries investment value today

Current value as on today

₹1,05,620

Returns

₹5,620

(+5.62%)

Returns from Teva Pharmaceutical Industries Stock

₹3,566 (+3.57%)

Dollar Returns

₹2,054 (+2.05%)

Indian investors sentiment towards Teva Pharmaceutical Industries (TEVA)

-28%

Period: Mar 18, 2025 to Apr 17, 2025. Change in 30 Days versus previous period

Search interest for Teva Pharmaceutical Industries Stock from India on INDmoney has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Teva Pharmaceutical Industries

  • FMR Inc

    7.23%

  • BlackRock Inc

    4.46%

  • Clal Insurance Enterprises Holdings Ltd

    3.44%

  • Ion Asset Management Ltd.

    3.23%

  • MENORA MIVTACHIM HOLDINGS LIMITED

    2.50%

  • Exor Investments (UK) LLP

    2.40%

Analyst Recommendation on Teva Pharmaceutical Industries

Rating
Trend

Sell

    0%Buy

    33%Hold

    66%Sell

Based on 9 Wall street analysts offering stock ratings for Teva Pharmaceutical Industries(by analysts ranked 0 to 5 stars)

Analyst Forecast on Teva Pharmaceutical Industries Stock (TEVA)

What analysts predicted

Upside of 67.65%

Target:

$22.88

Current:

$13.65

Insights on Teva Pharmaceutical Industries Stock (Ticker Symbol: TEVA)

  • Price Movement

    In the last 3 months, TEVA stock has moved down by -38.0%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 4.33B → 4.22B (in $), with an average decrease of 2.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -845.0M → -217.0M (in $), with an average increase of 97.4% per quarter
  • TEVA vs HLN (1 yr)

    In the last 1 year, Haleon Plc Spon Ads has given 24.8% return, outperforming this stock by 21.6%
  • Price to Sales

    ForTEVA every $1 of sales, investors are willing to pay $0.9, whereas for Haleon Plc Spon Ads, the investors are paying $4.1 for every $1 of sales.

TEVA Teva Pharmaceutical Industries Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$16.5B
↑ 4.4%
Net Income
$-1.6B
↑ 193.2%
Net Profit Margin
-9.91%
↓ 6.38%

Teva Pharmaceutical Industries Technicals Summary

Sell

Neutral

Buy

Teva Pharmaceutical Industries is currently in a neutral trading position according to technical analysis indicators.

Teva Pharmaceutical Industries (TEVA) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Teva Pharmaceutical Industries Ltd logo
-16.51%
-24.23%
6.42%
33.6%
31.78%
Haleon Plc Spon Ads logo
-1.65%
0.3%
24.48%
36.57%
36.57%
United Therapeutics Corporation logo
-9.33%
-22.69%
20.21%
54.59%
60.17%
Zoetis Inc. logo
-9.25%
-22.8%
-2.54%
-19.75%
17.14%

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders " chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
Organization
Teva Pharmaceutical Industries
Employees
33892
CEO
Mr. Richard D. Francis
Industry
Health Technology

Management People of Teva Pharmaceutical Industries

NameTitle
Mr. Richard D. Francis
President, CEO & Director
Mr. Eliyahu Sharon Kalif
Executive VP & CFO
Mr. Richard Gordon Daniell
Executive Vice President of European Commercial
Dr. Eric A. Hughes M.D., Ph.D.
Executive VP of Global R&D and Chief Medical Officer
Ms. Christine Fox
Executive VP of U.S. Commercial Business
Mr. Matthew Shields
Executive Vice President of Global Operations
Mr. Amir Weiss
Senior VP & Chief Accounting Officer
Mr. Christopher J. Stevo CFA
Senior Vice President of Investor Relations & Competitive Intelligence
Kathleen Veit
Senior Vice President, Global Compliance & Ethics Officer
Mr. David R. Mcavoy J.D.
Executive VP & Chief Legal Officer

Important FAQs about investing in TEVA Stock from India :

What is Teva Pharmaceutical Industries share price today?

Teva Pharmaceutical Industries share price today stands at $13.65, Open: $13.54 ; Previous Close: $13.43 ; High: $13.72 ; Low: $13.45 ; 52 Week High: $22.80 ; 52 Week Low: $12.47.

The stock opens at $13.54, after a previous close of $13.43. The stock reached a daily high of $13.72 and a low of $13.45, with a 52-week high of $22.80 and a 52-week low of $12.47.

Can Indians buy Teva Pharmaceutical Industries shares?

Yes, Indians can invest in the Teva Pharmaceutical Industries (TEVA) from India.

With INDmoney, you can buy Teva Pharmaceutical Industries at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Teva Pharmaceutical Industries at zero transaction cost.

How can I buy Teva Pharmaceutical Industries shares from India?

It is very easy to buy Teva Pharmaceutical Industries from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Teva Pharmaceutical Industries (TEVA) be purchased?

Yes, you can buy fractional shares of Teva Pharmaceutical Industries with INDmoney app.

What are the documents required to start investing in Teva Pharmaceutical Industries stocks?

To start investing in Teva Pharmaceutical Industries, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Teva Pharmaceutical Industries Stock (TEVA)?

Today’s highest price of Teva Pharmaceutical Industries (TEVA) is $13.72.

Today’s lowest price of Teva Pharmaceutical Industries (TEVA) is $13.45.

What is today's market capitalisation of Teva Pharmaceutical Industries?

Today's market capitalisation of Teva Pharmaceutical Industries TEVA is 15.6B

What is the 52 Week High and Low Range of Teva Pharmaceutical Industries Stock (TEVA)?

  • 52 Week High

    $22.80

  • 52 Week Low

    $12.47

What are the historical returns of Teva Pharmaceutical Industries (TEVA)?

  • 1 Month Returns

    -16.51%

  • 3 Months Returns

    -24.23%

  • 1 Year Returns

    6.42%

  • 5 Years Returns

    31.78%

Who is the Chief Executive Officer (CEO) of Teva Pharmaceutical Industries ?

Mr. Richard D. Francis is the current Chief Executive Officer (CEO) of Teva Pharmaceutical Industries.

Discover More